Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 April 2023 | Story EDZANI NEPHALELA | Photo CHARL DEVENISH
Magdalena de Koker accepts a posthumous degree on behalf of her late son, Mervin Hershel van Wyk.

A grieving mother brought tears to the eyes of almost everyone present during a graduation ceremony at the University of the Free State (UFS) on Thursday 20 April, when she took to the stage to accept her late son’s posthumously awarded master’s degree.

The usually festive and jovial graduation spirit inside the Callie Human Centre at the University of the Free State’s Bloemfontein Campus turned sombre in a matter of seconds as Magdalena de Koker ascended the stage to receive her son Mervin Hershel van Wyk’s degree. The Faculty of Theology and Religion student had been on track to receive a Master of Theology degree with a specialisation in Church History and Polity, but passed away before his graduation ceremony. The posthumous degree awarding honoured Van Wyk’s memory and acknowledged his family’s support throughout his academic journey.

“My emotions are conflicted,” De Koker said. “I feel a sense of pride for my son’s accomplishments, and eagerly anticipated celebrating his graduation. However, the profound loss of my son has left me devastated. Instead of being a spectator, cheering him on from the audience, I now find myself standing in his place on stage, wearing unfamiliar shoes, unsure where the toe or heel lies.” 

His legacy lives on

Before closing the ceremony Professor Bonang Mohale, Chancellor of the UFS, said he cried because this degree had to be conferred posthumously. 

“This is sad, tragic, and regrettable,” Prof Mohale said. “We all pray and hope that our children will bury us. Mama, we pray that you get peace by acknowledging the current trauma and pain, so that there can be some acceptance in order to start the process of healing. And with that process of healing comes forgiveness. The wonderful thing about forgiveness is that it allows more healing. May the good Jehovah be with the family and the whole clan. When we pray, we say ‘Thy will be done’. Thank you, in the wake of your pain, for making the time to be with this greater family of Kovsies.” 

Dr Eugene Fortein, Senior Lecturer in Church History and Polity, said his late student was an inspiration to many. “He firmly believed that God cared about the suffering of the impoverished and oppressed, and that justice would be served to those often overlooked. These convictions fuelled his involvement in politics, unafraid to use his Christian beliefs to advocate for change through protests. His trial sermon last year from Amos 5 – ‘But let justice roll on like a river, righteousness like a never-failing stream’ – embodied his unwavering conviction that justice and righteousness were integral to his faith.” 

Van Wyk’s passing is huge a loss for his family, friends, and the UFS and South African academic communities. His dedication and commitment to his studies serve as an inspiration to all those who knew him. The UFS community mourns the loss of a talented student and scholar, but his legacy will continue to live on through his contributions to the field of theology.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept